Search Login Register

Fibrinolysin Summary

Description: A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.

Also Known As: Aventis Pharma Brand of Plasmin; Fibrogammin; Glu-Plasmin; Protease F; Thrombolysin; Glu Plasmin; Plasmin

Networked: 1851 relevant articles (54 outcomes, 161 trials/studies) for this Drug

Key Diseases for which Fibrinolysin is Relevant

  1. Hemorrhage : 6 outcomes 3 studies in 98 results
  2. Vitreous Detachment (Posterior Vitreous Detachment) : 6 outcomes 1 study in 27 results
  3. Neoplasms (Cancer) : 4 outcomes 24 studies in 294 results
  4. Thrombosis (Thrombus) : 3 outcomes 10 studies in 175 results
  5. Macular Edema : 3 outcomes 1 study in 15 results
Show All >>

Drugs Related to Fibrinolysin

  1. Thrombin
  2. Fibrin
  3. Fibrinogen (Factor I)
  4. Serine Proteases (Serine Protease)
  5. Tissue Plasminogen Activator (Alteplase)
  6. fibrin fragment D (D-dimer)
  7. alpha-2-Antiplasmin (alpha 2 Antiplasmin)
  8. estropipate (Ogen)
  9. Aprotinin (Trasylol)
  10. Retinaldehyde (Retinal)
Show All >>

Therapies Related to Fibrinolysin

  1. Vitrectomy
  2. Intravitreal Injections
  3. Catheters
  4. Transplants (Transplant)
  5. Debridement
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.